Correction: Maranto et al. Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo. Cancers 2020, 12, 3412
Cristina Maranto, Vindhya Udhane, Jing Jia, Ranjit Verma, Gerhard Müller-Newen, Peter S. LaViolette, Michael Pereckas, Lavannya Sabharwal, Scott Terhune, Nagarajan Pattabiraman, Vincent C. O. Njar, John D. Imig, Liang Wang, Marja T. Nevalainen
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCytokine Signaling Pathways and Interactions · Cancer Mechanisms and Therapy · Inflammatory mediators and NSAID effects
Error in Figure
In the original publication [1], there was a mistake in Figure 5D as published. Accidentally the WB of Tyk2PY was inserted twice for both DU145 Jak1PY and CWR22Pc Tyk2PY. However, the correct WBs were presented in the PowerPoint presentation of the uncut WBs presented to the reviewers of the manuscript in the original submission verify that this was honest error in assembling the figure panel of multiple cropped images. The correct cropped image of the Jak1PY for DU145 cells has now been inserted in the revised Figure 5D figure panel.
In the original publication, there was a mistake in Figure 6 as published. In the figure panel of the lung images, the same image for 0 mg was accidentally inserted also as a representative image of lungs of mice treated with IST5 100 mg per day. The correct image has now been inserted to the revised Figure 6.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Maranto C. Udhane V. Jia J. Verma R. Müller-Newen G. La Violette P.S. Pereckas M. Sabharwal L. Terhune S. Pattabiraman N. Prospects for Clinical Development of Stat 5 Inhibitor IST 5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo Cancers 202012341210.3390/cancers 1211341233217941 PMC 7724566 · doi ↗ · pubmed ↗